Lupin’s arm inks pact to acquire 43.38% stake in Multicare Pharma

02 Apr 2026 Evaluate

Lupin’s wholly owned subsidiary -- Nanomi B.V., the Netherlands (Nanomi) has entered into definitive agreements to acquire the minority shareholding from certain existing shareholders of Multicare Pharmaceuticals Philippines, Inc. (MPPI), a subsidiary of Nanomi. This acquisition involves 11,794,497 shares, which accounts for 43.38% of the total outstanding paid up shares of MPPI. The transaction is expected to be completed by the end of May 2026, subject to certain closing conditions. 

The proposed acquisition will strengthen the company’s market standing in the Philippines market (through its wholly owned subsidiary Nanomi) and allow substantial integration of MPPI’s operations. It also allows strategic flexibility, enabling the company to unify emerging-market businesses and unlock long-term value.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2276.80 3.20 (0.14%)
02-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.65
Dr. Reddys Lab 1217.60
Cipla 1193.40
Zydus Lifesciences 864.25
Lupin 2276.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×